{"id":5370,"date":"2022-10-23T14:00:00","date_gmt":"2022-10-23T13:00:00","guid":{"rendered":"https:\/\/catapult.org.uk\/?post_type=case_study&#038;p=5370"},"modified":"2023-08-21T13:05:09","modified_gmt":"2023-08-21T12:05:09","slug":"the-psychiatry-consortium-exploring-new-treatments-for-mental-health-conditions","status":"publish","type":"case_study","link":"https:\/\/catapult.org.uk\/our-work\/case-studies\/the-psychiatry-consortium-exploring-new-treatments-for-mental-health-conditions\/","title":{"rendered":"The Psychiatry Consortium &#8211; exploring new treatments for mental health conditions"},"content":{"rendered":"\n<div style=\"height:54px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:10%\"><\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:90%\">\n<h1 class=\"wp-block-heading\">The Psychiatry Consortium &#8211; exploring new treatments for mental health conditions<\/h1>\n\n\n\n<div style=\"height:54px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"600\" src=\"https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/08\/MicrosoftTeams-image-13MDC.png\" alt=\"\" class=\"wp-image-5371\" srcset=\"https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/08\/MicrosoftTeams-image-13MDC.png 800w, https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/08\/MicrosoftTeams-image-13MDC-300x225.png 300w, https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/08\/MicrosoftTeams-image-13MDC-768x576.png 768w\" sizes=\"auto, (max-width: 800px) 100vw, 800px\" \/><\/figure><\/div>\n\n<div\n  class=\"mt-5 mb-5 blockQuote  position-relative\"\n  style=\"padding-left: 40px;border-left: solid #393D48 10px;\">\n    <svg class=\"pb-3\" width=\"26\" height=\"40\" viewBox=\"0 0 20 17\"\n    style=\"fill-rule:evenodd;clip-rule:evenodd;stroke-linejoin:round;stroke-miterlimit:2;\">\n    <path\n      d=\"M2.173,0l-2.173,7.704l0,8.796l8.15,0l-0,-8.667l-2.415,-0l1.328,-7.833l-4.89,0Zm11.35,0l-2.173,7.704l0,8.796l8.15,0l0,-8.667l-2.415,-0l1.329,-7.833l-4.891,0Z\"\n      style=\"fill:#FE5000;fill-rule:nonzero;\" \/>\n  <\/svg>\n      <p class=\"quoteContent\" style=\"color:black;\">\n    <em>At the moment, too many people living with a mental illness are going without the effective help they need. This Psychiatry Consortium is an important step in stimulating much-needed advances in the area<\/em>.   <\/p>\n  \n    <div class=\"quoteFooterContent pt-3 pb-3\"\n    style=\"font-size: 1.125rem; color: black;\">\n    <strong>Lea Milligan <\/strong><br>CEO, MQ at Transforming Mental Health  <\/div>\n  \n  \n    <div class=\"text-right\">\n    <svg width=\"26\" height=\"40\" viewBox=\"0 0 20 17\"\n      style=\"fill-rule:evenodd;clip-rule:evenodd;stroke-linejoin:round;stroke-miterlimit:2;\">\n      <path\n        d=\"M17.464,16.594l2.19,-7.748l-0,-8.846l-8.214,0l-0,8.716l2.434,0l-1.339,7.878l4.929,-0Zm-11.44,-0l2.19,-7.748l0,-8.846l-8.214,0l0,8.716l2.434,0l-1.339,7.878l4.929,-0Z\"\n        style=\"fill:#FE5000;fill-rule:nonzero;\" \/>\n    <\/svg>\n  <\/div>\n  <\/div>\n\n\n\n<div style=\"height:0px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p>Medicines discovery for challenging diseases requires a collaborative approach with a patient focus. In 2019 the Medicines Discovery Catapult established the Psychiatry Consortium as one of its patient focussed partnerships. It is a strategic collaboration of two leading medical research charities and seven international pharmaceutical companies, focusing on the unmet therapeutic needs of people living with mental health conditions.<\/p>\n\n\n\n<p>The scale and impact of mental illness are huge. One in ten children and one in four adults (approximately 15 million people) experience mental illness each year, affecting their wellbeing, relationships, and potential ability to work. The economic and social cost of mental illness has been estimated as \u00a3105 billion a year in England alone. There have been no new, effective types of treatment for over 30 years and new treatments are needed urgently.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p>The lack of novel drug targets combined with the challenge of validating them pre-clinically and the high failure rate in clinical trials have led to reduced investment in drug discovery and development in the last decade.<\/p>\n\n\n\n<p>The Psychiatry Consortium partners provide funding, collaboration, and knowledge exchange, to revitalise drug discovery in psychiatry by strengthening collaborations across the sector \u2013 committing approximately \u00a34 million in research funding to deliver up to 10 high-value drug discovery projects over three years.<\/p>\n\n\n\n<p>The Psychiatry Consortium has launched five calls for research projects and engaged with over 400 research institutions in 75 countries worldwide. It has created a partnership to investigate a new drug target for the treatment of schizophrenia and an international collaboration that seeks to define a new pharmacological approach to treat depression.<\/p>\n<\/div>\n<\/div>\n\n\n\n<div style=\"height:0px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div style=\"height:0px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n<div style=\"background-color: white;background:\"\n                    class=\"impactGrid pt-5 pb-5  alignwide\"\n                >        <div class=\"row\">            <div class=\"col-md-6 border-top-dashed border-bottom-sm-dashed border-right-sm-dashed pl-0 pr-4 pt-4 pb-4 impactGridTextColor d-flex align-items-center\"\n                                style=\"border-color:#FE5000;color:#FE5000;\"\n                            >                    <div class=\"col-md-12 d-flex flex-column justify-content-center\">                        <span class=\"figure\"\n                                            style=\"font-size:2.8125rem\"\n                                        >\n                                            \u00a34m\n                                        <\/span>\n\n                                        <br\/>\n\n                                        <div class=\"raleway font-weight-bold\">\n                                            new private funding for  psychiatric drug discovery\n                                        <\/div>                    <\/div>\n\n                                    <div class=\"col-4 col-sm-2 col-md-4 d-flex justify-content-center\">                    <\/div>\n\n                            <\/div>            <div class=\"col-md-6 border-top-dashed border-bottom-dashed pl-0 pr-4 pt-4 pb-4 impactGridTextColor d-flex align-items-center\"\n                                style=\"border-color:#FE5000;color:#FE5000;\"\n                            >                   <div class=\"col-md-12 d-flex flex-column justify-content-center\">                        <span class=\"figure\"\n                                            style=\"font-size:2.8125rem\"\n                                        >\n                                            400\n                                        <\/span>\n\n                                        <br\/>\n\n                                        <div class=\"raleway font-weight-bold\">\n                                            research institutions in 75  countries engaged\n                                        <\/div>                    <\/div>\n\n                                    <div class=\"col-4 col-sm-2 col-md-4 d-flex justify-content-center\">                    <\/div>\n\n                            <\/div>            <div class=\"col-md-6 border-bottom-dashed border-right-sm-dashed pl-0 pr-4 pt-4 pb-4 impactGridTextColor d-flex align-items-center\"\n                                style=\"border-color:#FE5000;color:#FE5000;\"\n                            >                    <div class=\"col-md-12 d-flex flex-column justify-content-center\">                        <span class=\"figure\"\n                                            style=\"font-size:2.8125rem\"\n                                        >\n                                            \n                                        <\/span>\n\n                                        <br\/>\n\n                                        <div class=\"raleway font-weight-bold\">\n                                            UK charities, SME and international  pharma coordinated\n                                        <\/div>                    <\/div>\n\n                                    <div class=\"col-4 col-sm-2 col-md-4 d-flex justify-content-center\">                    <\/div>                              \n\n                            <\/div>            <div class=\"col-md-6 border-bottom-dashed pl-0 pr-4 pt-4 pb-4 impactGridTextColor d-flex align-items-center\"\n                                style=\"border-color:#FE5000;color:#FE5000;\"\n                            >                    <div class=\"col-md-12 d-flex flex-column justify-content-center\">                        <span class=\"figure\"\n                                            style=\"font-size:2.8125rem\"\n                                        >\n                                            5\n                                        <\/span>\n\n                                        <br\/>\n\n                                        <div class=\"raleway font-weight-bold\">\n                                            calls for research project launched by the Consortium since its establishment in 2019\n                                        <\/div>                    <\/div>\n\n                                    <div class=\"col-4 col-sm-2 col-md-4 d-flex justify-content-center\">                    <\/div>\n\n                            <\/div>\n\n                        <\/div>    \n\n                <\/div>\n\n\n<div style=\"height:0px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n<div class=\"wp-block-image is-style-rounded\">\n<figure class=\"aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/09\/psychiatry-consortium-MDC-1024x683.jpg\" alt=\"\" class=\"wp-image-5608\" srcset=\"https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/09\/psychiatry-consortium-MDC-1024x683.jpg 1024w, https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/09\/psychiatry-consortium-MDC-300x200.jpg 300w, https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/09\/psychiatry-consortium-MDC-768x512.jpg 768w, https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/09\/psychiatry-consortium-MDC-1536x1024.jpg 1536w, https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/09\/psychiatry-consortium-MDC-2048x1365.jpg 2048w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure><\/div>\n\n\n<p><\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:10%\"><\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><\/div>\n<\/div>\n\n\n\n<div style=\"height:40px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Medicines discovery for challenging diseases requires a collaborative approach with a patient focus. In 2019 the Medicines Discovery Catapult established the Psychiatry Consortium as one of its patient focussed partnerships. It is a strategic collaboration of two leading medical research charities and seven international pharmaceutical companies, focusing on the unmet therapeutic needs of people living with mental health conditions.<\/p>\n","protected":false},"featured_media":5371,"template":"","meta":{"_external_link_checkbox":false,"_external_link":"","_event_date":"","_featured_case_study":false},"categories":[10],"tags":[61,63],"class_list":["post-5370","case_study","type-case_study","status-publish","has-post-thumbnail","hentry","category-medicines-discovery","tag-catapult-highlights","tag-leverage"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>The Psychiatry Consortium - exploring new treatments for mental health conditions - The Catapult Network<\/title>\n<meta name=\"description\" content=\"Medicines discovery for challenging diseases requires a collaborative approach with a patient focus. In 2019 the Medicines Discovery Catapult established the Psychiatry Consortium as one of its patient focussed partnerships. It is a strategic collaboration of two leading medical research charities and seven international pharmaceutical companies, focusing on the unmet therapeutic needs of people living with mental health conditions.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/catapult.org.uk\/our-work\/case-studies\/the-psychiatry-consortium-exploring-new-treatments-for-mental-health-conditions\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Psychiatry Consortium - exploring new treatments for mental health conditions - The Catapult Network\" \/>\n<meta property=\"og:description\" content=\"Medicines discovery for challenging diseases requires a collaborative approach with a patient focus. In 2019 the Medicines Discovery Catapult established the Psychiatry Consortium as one of its patient focussed partnerships. It is a strategic collaboration of two leading medical research charities and seven international pharmaceutical companies, focusing on the unmet therapeutic needs of people living with mental health conditions.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/catapult.org.uk\/our-work\/case-studies\/the-psychiatry-consortium-exploring-new-treatments-for-mental-health-conditions\/\" \/>\n<meta property=\"og:site_name\" content=\"The Catapult Network\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-21T12:05:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/08\/MicrosoftTeams-image-13MDC.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@Catapult_UK\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/catapult.org.uk\/our-work\/case-studies\/the-psychiatry-consortium-exploring-new-treatments-for-mental-health-conditions\/\",\"url\":\"https:\/\/catapult.org.uk\/our-work\/case-studies\/the-psychiatry-consortium-exploring-new-treatments-for-mental-health-conditions\/\",\"name\":\"The Psychiatry Consortium - exploring new treatments for mental health conditions - The Catapult Network\",\"isPartOf\":{\"@id\":\"https:\/\/catapult.org.uk\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/catapult.org.uk\/our-work\/case-studies\/the-psychiatry-consortium-exploring-new-treatments-for-mental-health-conditions\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/catapult.org.uk\/our-work\/case-studies\/the-psychiatry-consortium-exploring-new-treatments-for-mental-health-conditions\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/08\/MicrosoftTeams-image-13MDC.png\",\"datePublished\":\"2022-10-23T13:00:00+00:00\",\"dateModified\":\"2023-08-21T12:05:09+00:00\",\"description\":\"Medicines discovery for challenging diseases requires a collaborative approach with a patient focus. In 2019 the Medicines Discovery Catapult established the Psychiatry Consortium as one of its patient focussed partnerships. It is a strategic collaboration of two leading medical research charities and seven international pharmaceutical companies, focusing on the unmet therapeutic needs of people living with mental health conditions.\",\"breadcrumb\":{\"@id\":\"https:\/\/catapult.org.uk\/our-work\/case-studies\/the-psychiatry-consortium-exploring-new-treatments-for-mental-health-conditions\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/catapult.org.uk\/our-work\/case-studies\/the-psychiatry-consortium-exploring-new-treatments-for-mental-health-conditions\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/catapult.org.uk\/our-work\/case-studies\/the-psychiatry-consortium-exploring-new-treatments-for-mental-health-conditions\/#primaryimage\",\"url\":\"https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/08\/MicrosoftTeams-image-13MDC.png\",\"contentUrl\":\"https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/08\/MicrosoftTeams-image-13MDC.png\",\"width\":800,\"height\":600},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/catapult.org.uk\/our-work\/case-studies\/the-psychiatry-consortium-exploring-new-treatments-for-mental-health-conditions\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/catapult.org.uk\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Case Studies\",\"item\":\"https:\/\/catapult.org.uk\/our-work\/case-studies\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"The Psychiatry Consortium &#8211; exploring new treatments for mental health conditions\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/catapult.org.uk\/#website\",\"url\":\"https:\/\/catapult.org.uk\/\",\"name\":\"The Catapult Network\",\"description\":\"The Innovate UK Catapult Network\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/catapult.org.uk\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Psychiatry Consortium - exploring new treatments for mental health conditions - The Catapult Network","description":"Medicines discovery for challenging diseases requires a collaborative approach with a patient focus. In 2019 the Medicines Discovery Catapult established the Psychiatry Consortium as one of its patient focussed partnerships. It is a strategic collaboration of two leading medical research charities and seven international pharmaceutical companies, focusing on the unmet therapeutic needs of people living with mental health conditions.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/catapult.org.uk\/our-work\/case-studies\/the-psychiatry-consortium-exploring-new-treatments-for-mental-health-conditions\/","og_locale":"en_GB","og_type":"article","og_title":"The Psychiatry Consortium - exploring new treatments for mental health conditions - The Catapult Network","og_description":"Medicines discovery for challenging diseases requires a collaborative approach with a patient focus. In 2019 the Medicines Discovery Catapult established the Psychiatry Consortium as one of its patient focussed partnerships. It is a strategic collaboration of two leading medical research charities and seven international pharmaceutical companies, focusing on the unmet therapeutic needs of people living with mental health conditions.","og_url":"https:\/\/catapult.org.uk\/our-work\/case-studies\/the-psychiatry-consortium-exploring-new-treatments-for-mental-health-conditions\/","og_site_name":"The Catapult Network","article_modified_time":"2023-08-21T12:05:09+00:00","og_image":[{"width":800,"height":600,"url":"https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/08\/MicrosoftTeams-image-13MDC.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@Catapult_UK","twitter_misc":{"Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/catapult.org.uk\/our-work\/case-studies\/the-psychiatry-consortium-exploring-new-treatments-for-mental-health-conditions\/","url":"https:\/\/catapult.org.uk\/our-work\/case-studies\/the-psychiatry-consortium-exploring-new-treatments-for-mental-health-conditions\/","name":"The Psychiatry Consortium - exploring new treatments for mental health conditions - The Catapult Network","isPartOf":{"@id":"https:\/\/catapult.org.uk\/#website"},"primaryImageOfPage":{"@id":"https:\/\/catapult.org.uk\/our-work\/case-studies\/the-psychiatry-consortium-exploring-new-treatments-for-mental-health-conditions\/#primaryimage"},"image":{"@id":"https:\/\/catapult.org.uk\/our-work\/case-studies\/the-psychiatry-consortium-exploring-new-treatments-for-mental-health-conditions\/#primaryimage"},"thumbnailUrl":"https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/08\/MicrosoftTeams-image-13MDC.png","datePublished":"2022-10-23T13:00:00+00:00","dateModified":"2023-08-21T12:05:09+00:00","description":"Medicines discovery for challenging diseases requires a collaborative approach with a patient focus. In 2019 the Medicines Discovery Catapult established the Psychiatry Consortium as one of its patient focussed partnerships. It is a strategic collaboration of two leading medical research charities and seven international pharmaceutical companies, focusing on the unmet therapeutic needs of people living with mental health conditions.","breadcrumb":{"@id":"https:\/\/catapult.org.uk\/our-work\/case-studies\/the-psychiatry-consortium-exploring-new-treatments-for-mental-health-conditions\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/catapult.org.uk\/our-work\/case-studies\/the-psychiatry-consortium-exploring-new-treatments-for-mental-health-conditions\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/catapult.org.uk\/our-work\/case-studies\/the-psychiatry-consortium-exploring-new-treatments-for-mental-health-conditions\/#primaryimage","url":"https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/08\/MicrosoftTeams-image-13MDC.png","contentUrl":"https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/08\/MicrosoftTeams-image-13MDC.png","width":800,"height":600},{"@type":"BreadcrumbList","@id":"https:\/\/catapult.org.uk\/our-work\/case-studies\/the-psychiatry-consortium-exploring-new-treatments-for-mental-health-conditions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/catapult.org.uk\/"},{"@type":"ListItem","position":2,"name":"Case Studies","item":"https:\/\/catapult.org.uk\/our-work\/case-studies\/"},{"@type":"ListItem","position":3,"name":"The Psychiatry Consortium &#8211; exploring new treatments for mental health conditions"}]},{"@type":"WebSite","@id":"https:\/\/catapult.org.uk\/#website","url":"https:\/\/catapult.org.uk\/","name":"The Catapult Network","description":"The Innovate UK Catapult Network","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/catapult.org.uk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"}]}},"_links":{"self":[{"href":"https:\/\/catapult.org.uk\/wp-json\/wp\/v2\/case_study\/5370","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/catapult.org.uk\/wp-json\/wp\/v2\/case_study"}],"about":[{"href":"https:\/\/catapult.org.uk\/wp-json\/wp\/v2\/types\/case_study"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/catapult.org.uk\/wp-json\/wp\/v2\/media\/5371"}],"wp:attachment":[{"href":"https:\/\/catapult.org.uk\/wp-json\/wp\/v2\/media?parent=5370"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/catapult.org.uk\/wp-json\/wp\/v2\/categories?post=5370"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/catapult.org.uk\/wp-json\/wp\/v2\/tags?post=5370"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}